R. W. Frost

发表

Effects of aluminum hydroxide and calcium carbonate antacids on the bioavailability of ciprofloxacin

K. Lasseter, J. Lettieri, R. W. Frost, 1992, Antimicrobial Agents and Chemotherapy.

The Effect of Sucralfate Pretreatment on the Pharmacokinetics of Ciprofloxacin

W. Watson, D. Nix, H. Goldstein, 1989, Pharmacotherapy.

Effects of cardiopulmonary bypass surgery on intravenous ciprofloxacin disposition

S. Levitsky, J. Lettieri, K. Rodvold, 1993, Antimicrobial Agents and Chemotherapy.

Human Cytomegalovirus Utilizes a Nontraditional Signal Transducer and Activator of Transcription 1 Activation Cascade via Signaling through Epidermal Growth Factor Receptor and Integrins To Efficiently Promote the Motility, Differentiation, and Polarization of Infected Monocytes

Byeong-Jae Lee, G. Chan, A. Yurochko, 2017, Journal of Virology.

HCMV utilizes a non-traditional STAT1 activation cascade via signaling through EGFR and integrins to efficiently promote the motility, differentiation, and polarization of infected monocytes

Byeong-Jae Lee, G. Chan, A. Yurochko, 2017 .

Microbiological investigation of polyarthralgia.

J. Pether, J. W. Jones, R. W. Frost, 1995, Journal of clinical pathology.

Inhibition of Cerebrospinal Fluid Formation by a Carbonic Anhydrase Inhibitor, 2-Acetylamino-1, 3, 4-Thiadiazole-5-Sulfonamide (Diamox).∗

J. L. Taylor, R. D. Tschirgi, R. W. Frost, 1954, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Effects of aluminum and magnesium antacids and ranitidine on the absorption of ciprofloxacin

Jerome J. Schentag, W. Watson, J. Lettieri, 1989, Clinical pharmacology and therapeutics.

Ciprofloxacin Pharmacokinetics After a Standard or High‐Fat/High‐Calcium Breakfast

A. Dietz, J. Lettieri, A. Heyd, 1989, Journal of clinical pharmacology.

Alteration in the pharmacokinetic disposition of ciprofloxacin by simultaneous administration of azlocillin

S. Barriere, D. Catlin, P. Orlando, 1990, Antimicrobial Agents and Chemotherapy.

Relative bioavailability in healthy volunteers of ciprofloxacin administered through a nasogastric tube with and without enteral feeding

J. Lettieri, R. Quintiliani, C. Nightingale, 1989, Antimicrobial Agents and Chemotherapy.

Human parvovirus B19: Hard to differentiate from infectious mononucleosis

J. Pether, J. W. Jones, R. W. Frost, 1994, BMJ.

Physiologic considerations in drug absorption from the gastrointestinal tract.

A. Golub, M. A. González, C. Betlach, 1986, The Journal of allergy and clinical immunology.

Bioavailability and Pharmacokinetics of a New Sustained-Release Potassium Chloride Tablet

Mario A. González, P. Leese, J. Arnold, 1987, Pharmaceutical Research.

The effect of cirrhosis on the steady‐state pharmacokinetics of oral ciprofloxacin

K. Lasseter, J. Lettieri, G. Krol, 1989, Clinical pharmacology and therapeutics.

Serum bactericidal activity from intravenous ciprofloxacin and azlocillin given alone and in combination to healthy subjects.

J. Hindler, S. Barriere, P. Orlando, 1990, Diagnostic microbiology and infectious disease.

Byeong-Jae Lee, G. Chan, A. Yurochko, 2017, Journal of Virology.